SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-15-001911
Filing Date
2015-04-10
Accepted
2015-04-10 11:49:30
Documents
4
Period of Report
2015-05-20
Effectiveness Date
2015-04-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_041015.htm DEF 14A 1330283
2 logo.jpg GRAPHIC 6569
3 proxycard_1.jpg GRAPHIC 205049
4 proxycard_2.jpg GRAPHIC 154413
  Complete submission text file 0001171843-15-001911.txt   1836029
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 15763149
SIC: 2836 Biological Products, (No Diagnostic Substances)